Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of Decitabine in Combination With Midostaurin (PKC412) for Elderly Patients With Newly Diagnosed FLT3-ITD/TKD Positive Acute Myeloid Leukemia

NCT01846624 is registered in ClinicalTrials.gov with David Iberri as lead sponsor.

NCT NCT01846624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01846624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of Decitabine in Combination With Midostaurin (PKC412) for Elderly Patients With Newly Diagnosed FLT3-ITD/TKD Positive Acute Myeloid Leukemia
Lead sponsor
David Iberri
Phase
Phase 2
Overall status
Terminated
Start date
June 30, 2013
Completion date
August 31, 2016
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia (aml) with multilineage dysplasia following myelodysplastic syndrome, in adults, aml (adult) with 11q23 (mll) abnormalities, aml (adult) with del (5q), aml (adult) with inv (16) (p13; q22), aml (adult) with t (16;16) (p13; q22), aml (adult) with t (8; 21) (q22; q22), secondary aml (adult), untreated aml (adult)